Skip to content
All Podcasts – Lifestyle
Author:
NeOnc Technologies Holdings, Inc.
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
April 1, 2026
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
March 13, 2026
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
March 5, 2026
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
March 5, 2026
←
Previous Page
1
2